Year: 2015
Type: article
Abstract: MicroRNAs (miRNAs) are a class of small non-coding RNAs that negatively regulate gene expression by base pairing to partially complementary sites within the 3′-untranslated regions (3′UTR) of target messenger RNAs (mRNA) [ 1 ]. Binding of miRNA to its target mRNA causes translation repression [ 2 ] and/or mRNA degradation [ 3 ]. Genome-wide profiling of miRNA expression in cancer samples and their corresponding normal tissues showed a distinguished signature between tumoral and normal cells [ 4 , 5 ], which is often associated with cancer prognosis and progression [ 6 – 8 ]. In particular, a well-characterized polycistronic miRNA cluster, the miR-17-92 family, accomplishes pleiotrophic functions in cancer [ 9 , 10 ]. It is highly conserved among vertebrates [ 11 ] and has two mammalian paralogs: the miR-106a-363 and the miR-106b-25 cluster [ 12 ]. The miRNAs encoded by miR-17-92 and its two paralogs can be categorized into four “seed” families according to their seed sequences: miR-17 family (including miR-17, miR-20a, miR-20b, miR-106a, miR-106b and miR-93), miR-18 family (miR-18a and miR-18b), miR-19 family (miR-19a, miR-19b-1 and miR-19b-2), and miR-92 family (miR-92a-1, miR-92a-2, miR-25, and miR-363) [ 13 ]. Overexpression of the miR-17-92 cluster has been observed in a variety of hematological malignancies and solid tumors including B cell lymphoma, B cell chronic lymphocytic leukemia (CLL), retinoblastoma, meduloblastoma, osteosarcoma, and cancers of the colon, pancreas, breast, lung, kidney, and liver (as reviewed in [ 13 ]). The miRNA members of the miR-17-92 cluster contribute to cancer pathogenesis by directly regulating genes associated with cell growth and proliferation. The miR-17 family (miR-17 and miR-20a) triggers rapid proliferation by repressing the cell cycle inhibitors p21 (CDKN1A) and p57 (CDKN1C) [ 14 , 15 ] as well as by directly targeting the proapoptotic protein Bim (BCL211) [ 16 ] and the tumor suppressor gene phosphatase and tensin homolg (PTEN) [ 17 ]. Furthermore, they also regulate genes that mold the conditions for cellular proliferation. miR-17-92 blocks the production of transforming growth factor (TGF)-β-dependent antiangiogenic factors through suppressing the TGF-β receptor II (TGFBRII), Smad2, and Smad4 [ 18 ] whereas miR-18a and miR-19 promotes angiogenesis by directly targeting thrombospondin 1 (TSP-1) and connective tissue growth factor (CTGF), respectively [ 19 ].
Source: Journal of Molecular Medicine
Authors: Kamesh R. Babu, Martina U. Muckenthaler
Institution: Heidelberg University
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Keywords: miR-20a, ferroportin, iron export, lung cancer, miR-17-92 cluster, microRNA regulation, iron metabolism, gene expression regulation, translation repression, mRNA degradation, 3' untranslated region, microRNA binding sites, microRNA overexpression, tumor progression, prognosis, cell proliferation, cell migration, cell invasion, cell cycle, apoptosis
Open Access status: hybrid
Estimated APC paid: $4,390
OpenAlex ID: W2147072294
